Raphael Borok

1.6k total citations
16 papers, 1.2k citations indexed

About

Raphael Borok is a scholar working on Hematology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Raphael Borok has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Nephrology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Raphael Borok's work include Acute Myeloid Leukemia Research (6 papers), Renal Diseases and Glomerulopathies (4 papers) and Hematological disorders and diagnostics (3 papers). Raphael Borok is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Renal Diseases and Glomerulopathies (4 papers) and Hematological disorders and diagnostics (3 papers). Raphael Borok collaborates with scholars based in United States, Italy and Colombia. Raphael Borok's co-authors include Melvin M. Schwartz, Stephen M. Korbet, Rosangela Genchi, Suneel Mundle, Azra Raza, Sefer Gezer, Agapi Parcharidou, V. Shetty, Amna Iftikhar and S. Alvi and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Raphael Borok

16 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raphael Borok United States 11 525 482 330 191 178 16 1.2k
L Gugliotta Italy 21 957 1.8× 137 0.3× 246 0.7× 622 3.3× 363 2.0× 66 1.4k
Samar M. Said United States 22 235 0.4× 939 1.9× 969 2.9× 241 1.3× 194 1.1× 67 1.7k
John Dervenoulas Greece 17 345 0.7× 57 0.1× 297 0.9× 201 1.1× 168 0.9× 56 940
Benedetto Comotti Italy 14 573 1.1× 53 0.1× 334 1.0× 316 1.7× 112 0.6× 29 1.2k
Magali Colombat France 21 124 0.2× 278 0.6× 461 1.4× 110 0.6× 229 1.3× 92 1.5k
JB Bussel United States 6 2.0k 3.8× 354 0.7× 71 0.2× 217 1.1× 435 2.4× 9 2.3k
Aruna Raghavachar Germany 22 1.5k 2.8× 84 0.2× 357 1.1× 495 2.6× 516 2.9× 55 2.1k
E. Papageorgiou Greece 20 341 0.6× 51 0.1× 160 0.5× 220 1.2× 131 0.7× 48 866
Masanao Teramura Japan 16 565 1.1× 94 0.2× 74 0.2× 184 1.0× 333 1.9× 43 872
H. Heimpel Germany 15 706 1.3× 53 0.1× 113 0.3× 295 1.5× 326 1.8× 38 1.1k

Countries citing papers authored by Raphael Borok

Since Specialization
Citations

This map shows the geographic impact of Raphael Borok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Borok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Borok more than expected).

Fields of papers citing papers by Raphael Borok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael Borok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Borok. The network helps show where Raphael Borok may publish in the future.

Co-authorship network of co-authors of Raphael Borok

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael Borok. A scholar is included among the top collaborators of Raphael Borok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael Borok. Raphael Borok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gupta, Rajarsi, et al.. (2019). Overview of established and emerging immunohistochemical biomarkers and their role in correlative studies in MRI. Journal of Magnetic Resonance Imaging. 51(2). 341–354. 4 indexed citations
2.
Shell, Scott A., et al.. (2014). Correlation of multiplex measurement of mRNA expression from FFPE tissues with protein expression.. Journal of Clinical Oncology. 32(15_suppl). e22141–e22141. 1 indexed citations
3.
Anderson, Joseph, Vijaya Reddy, Linda K. Green, et al.. (2002). Role of Expression of Cell Cycle Inhibitor p27 and MIB-1 in Predicting Lymph Node Metastasis in Male Breast Carcinoma. The Breast Journal. 8(2). 101–107. 9 indexed citations
4.
Alvi, Sairah, Vilasini Shetty, Francesca Zorat, et al.. (2001). Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes. Leukemia Research. 25(11). 941–954. 24 indexed citations
5.
Shetty, V., Suneel Mundle, Laurie Lisak, et al.. (2000). The Clinical and Biologic Significance of Abnormal Lipid Profiles in Patients with Myelodysplastic Syndromes. Journal of Hematotherapy & Stem Cell Research. 9(2). 247–255. 34 indexed citations
6.
Shetty, Vilasini, Krishnan Allampallam, Suneel Mundle, et al.. (2000). Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates. Blood. 96(4). 1388–1392. 3 indexed citations
7.
Shetty, Vilasini, Krishnan Allampallam, Suneel Mundle, et al.. (2000). Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates. Blood. 96(4). 1388–1392. 63 indexed citations
8.
Marcus, Richard H., James Bednarz, Raphael Borok, et al.. (1998). Assessment of Small-Diameter Aortic Mechanical Prostheses. Circulation. 98(9). 866–872. 13 indexed citations
9.
Gattuso, Paolo, K. Bloom, Raphael Borok, et al.. (1998). Marker Panel Predictive of Lymph Node Metastasis in Young Patients with Breast Carcinoma. International Journal of Surgical Pathology. 6(2). 55–60. 3 indexed citations
10.
Shetty, Vilasini, Suneel Mundle, Sairah Alvi, et al.. (1996). Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leukemia Research. 20(11-12). 891–900. 156 indexed citations
11.
Korbet, Stephen M., Rosangela Genchi, Raphael Borok, & Melvin M. Schwartz. (1996). The racial prevalence of glomerular lesions in nephrotic adults. American Journal of Kidney Diseases. 27(5). 647–651. 173 indexed citations
12.
Sloan, Richard P., Melvin M. Schwartz, Stephen M. Korbet, & Raphael Borok. (1996). Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. Lupus Nephritis Collaborative Study Group.. Journal of the American Society of Nephrology. 7(2). 299–305. 91 indexed citations
13.
Korbet, Stephen M., et al.. (1995). Focal segmental glomerular sclerosis in adults: Presentation, course, and response to treatment. American Journal of Kidney Diseases. 25(4). 534–542. 189 indexed citations
14.
Schwartz, Melvin M., et al.. (1995). Primary focal segmental glomerular sclerosis in adults: Prognostic value of histologic variants. American Journal of Kidney Diseases. 25(6). 845–852. 66 indexed citations
15.
Raza, Azra, Sefer Gezer, Suneel Mundle, et al.. (1995). Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes [see comments]. Blood. 86(1). 268–276. 356 indexed citations
16.
Jf, Murray, et al.. (1957). Benign pulmonary histoplasmosis (cave disease) in South Africa.. PubMed. 31(11). 245–53. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026